Skip to main content
OpenTrials
Completed

NCT Number: NCT00518141

Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)

This study aims to determine the possible effects of Acetyl Salicylic Acid (ASA) and Terbutalin on ART treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Reproductive Techniques, Assisted Behavior Helping Behavior Social Behavior

Age range

18 year–39 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

STHF, Kvinneklinikken, Fertilitetsklinikken Sor

Porsgrunn, Telemark, 3901, Norway

About this study

This study aims to determine the possible effects of ASA and Terbutalin on ART treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Infertile women below 39 years of age

Exclusion criteria

  • Women who may react allergically to the drugs administered
  • Women with hyperthyroid or IDDM
  • Women who do not want to participate in the study
  • Women who are unable to give informed, written consent.

Treatment and study plan

Acetyl Salicylic Acid and Terbutalin

Drug

ASA 75 mg, Terbutalin 5mg

Primary outcomes

  1. Pregnancy

    Time frame: 7 weeks

Sponsors and collaborators

Lead sponsor

Sykehuset Telemark

Other Gov

Registry information

Official study title

Use of Acetylsalicylic Acid and Terbutalin in ART

Important dates

Study start
2006
Primary completion
2009
Study completion
2009
First posted
Aug 20, 2007
Registry last updated
Jul 21, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.